Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIngenta Regulatory News (ING)

Share Price Information for Ingenta (ING)

Share Price is delayed by 15 minutes
Get Live Data
68.50    -16.00 (-18.93%)
Bid:
67.00
Ask:
70.00
Spread: 3.00 (4.478%)
Market Cap: £9.94m
ING Live PriceLast checked at - London Stock Exchange

Intraday Ingenta Share Chart

Trading Statement

30 Jan 2019 07:00

RNS Number : 4661O
Ingenta PLC
30 January 2019
 

The information contained within this announcement (the "Announcement") is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this Announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

30 January 2019

 

Ingenta plc("Ingenta" or the "Group")

Trading Update

Ingenta plc (AIM: ING), a leading software and services provider to the publishing and media industry, provides the following trading update for the year ended 31 December 2018.

The Group is pleased to confirm that it has made considerable progress in its business combination plans, moving away from a divisional product siloed structure, which will enable the Group to operate in a more efficient and nimble manner going forward. The Group expects to report revenue of £12m and adjusted EBITDA of approximately £0.8 million. The Group generated operating cash inflows of £2.3m in the year, before expenditure on research and development of £1.8m, acquisition costs of £0.25m, dividends of £0.25m and the planned reorganisation costs of £0.8m, resulting in net cash balances at year-end of £1.3 million.

During the year, the business took the opportunity to impair its non-core Chinese joint venture investment and goodwill from legacy business combinations by £0.3m and £0.6m respectively, both of which were non-cash transactions.

Progress made by Ingenta's management over the past 18 months to reorganise and reposition the business have resulted in cumulative cost reductions of approximately £4m on an annualised basis. These efforts have substantially de-risked the Company, enabling it to produce increased profitability from a lower revenue base and allowing us to look forward to 2019 with considerable optimism.

The Board confirms its intention to pay a dividend of 1.5 pence per ordinary share for the 2018 financial year and intends to announce its final results for 2018 in March, subject to shareholder approval at the AGM.

Scott Winner, Chief Executive Officer, commented:

"The results of our recent business combination plan are now starting to produce results and I look forward to 2019 with great enthusiasm. The business is now leaner and focussed on delivering first class services to all our customers meaning we are significantly better placed to propel the business through the next stage of its growth".

 

For further information contact:

 

Ingenta PlcScott Winner, Jon Sheffield

+44 (0) 1865 397 800

Cenkos Securities plcNicholas Wells, Harry Hargreaves

+44 (0) 20 7397 8900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPGUACGUPBGRB
Date   Source Headline
25th Jun 20267:00 amRNSAGM Trading Update
1st May 20267:01 amRNS-RInvestor Presentation via Investor Meet Company
1st May 20267:00 amRNSPosting of Annual Report & Notice of AGM
27th Apr 20267:00 amRNSFinal Results
22nd Jan 20267:00 amRNSTrading Update
18th Nov 20254:30 pmRNSHolding(s) in Company
18th Nov 20254:29 pmRNSHolding(s) in Company
4th Nov 20253:21 pmRNSHolding(s) in Company
7th Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20255:27 pmRNSHolding(s) in Company
18th Sep 202511:00 amRNSInvestor Presentation via Investor Meet Company
15th Sep 20257:00 amRNSHalf-year Report
26th Jun 20254:42 pmRNSResult of Annual General Meeting
7th May 20254:54 pmRNSPosting of Annual Report & Notice of AGM
28th Apr 20257:00 amRNSFinal Results
7th Feb 20257:00 amRNSTrading Update
15th Nov 20244:52 pmRNSHolding(s) in Company
18th Sep 20247:00 amRNSHalf-year Report
18th Jul 20244:42 pmRNSResult of AGM and Directorate Change
3rd Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20244:30 pmRNSPosting of Annual Report & Notice of AGM
3rd Jun 20247:00 amRNSDirector/PDMR Shareholding
31st May 20247:00 amRNSInvestor Presentation via Investor Meet Company
28th May 20247:00 amRNSFinal Results
17th May 20242:20 pmRNSFinal Results Update
31st Jan 20247:00 amRNSTrading Update
25th Oct 20233:57 pmRNSChange of Nomad and Broker
17th Oct 20235:41 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSNew customer wins
11th Sep 20237:00 amRNSHalf-year Report
8th Sep 20232:44 pmRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSTrading Update
29th Jun 202312:52 pmRNSResult of AGM & Dividend Timetable
29th Jun 20237:00 amRNSAGM statement and contract wins
25th May 20234:00 pmRNSPosting of Annual Report & Notice of AGM
17th May 20237:00 amRNSInvestor Presentation via Investor Meet Company
11th May 20237:00 amRNSFinal Results
28th Apr 20237:00 amRNSNotice of Final Results
2nd Feb 20237:00 amRNSTrading Update
2nd Dec 20226:02 pmRNSDirector/PDMR Shareholding
16th Nov 20224:31 pmRNSHolding(s) in Company
14th Nov 20223:57 pmRNSResult of Tender Offer
11th Nov 202211:24 amRNSResult of General Meeting
25th Oct 20227:00 amRNSProposed Tender Offer & Notice of General Meeting
21st Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
3rd Aug 20222:09 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSTrading Update
28th Jul 20223:02 pmRNSResult of AGM and Dividend Timetable
8th Jul 20227:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.